Company Tonix Pharmaceuticals Holding Corp Nasdaq
Equities
US8902602015
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Therapeutics
100.0
%
| 0 | nan % | 8 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 8 | 100.0 % | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 84,490,862 | 84,485,661 ( 99.99 %) | 0 | 99.99 % |
Company contact information
Tonix Pharmaceuticals Holding Corp.
26 Main Street Suite 101
07928, Chatham
+862 799 8599
http://www.tonixpharma.comSector
1st Jan change | Capi. | |
---|---|---|
-3.35% | 88.91B | |
+4.08% | 41.25B | |
-14.96% | 31.99B | |
+51.65% | 24.73B | |
-14.61% | 15.54B | |
-40.39% | 12.07B | |
-8.63% | 12.05B | |
-14.92% | 12.02B | |
+6.22% | 8.84B |
- Stock Market
- Equities
- TNXP Stock
- Stock
- Company Tonix Pharmaceuticals Holding Corp